European stop tyrosine kinase inhibitor trial (EURO-SKI) in chronic myeloid leukemia: fanalysis and novel prognostic factors for treatment-free remission

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F24%3A00013646" target="_blank" >RIV/00023736:_____/24:00013646 - isvavai.cz</a>

Result on the web

<a href="https://doi.org/10.1200/JCO.23.01647" target="_blank" >https://doi.org/10.1200/JCO.23.01647</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1200/JCO.23.01647" target="_blank" >10.1200/JCO.23.01647</a>

Result language

angličtina

Original language name

European stop tyrosine kinase inhibitor trial (EURO-SKI) in chronic myeloid leukemia: fanalysis and novel prognostic factors for treatment-free remission

Original language description

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30205 - Hematology

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2024

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Journal of clinical oncology

ISSN

0732-183X

e-ISSN

—

Volume of the periodical

42

Issue of the periodical within the volume

16

Country of publishing house

DE - GERMANY

Number of pages

11

Pages from-to

1875-1880

UT code for WoS article

001279720300007

EID of the result in the Scopus database

2-s2.0-85193806512